Odyssey Therapeutics (ODTX) Return on Sales [ROS] (2023 - 2026)
Odyssey Therapeutics (ODTX) posted Return on Sales [ROS] of -173008.08% for Q2 2026, down 168636.76 percentage points from -4371.32% a year earlier and down 158099.86 percentage points from the prior quarter.
Odyssey Therapeutics (ODTX) Return on Sales [ROS] (2023 - 2026) Analysis & Trends
For FY2025, Odyssey Therapeutics' Return on Sales [ROS] came in at -5279.20%, down 2215.22 percentage points from FY2024.
- In prior years, Odyssey Therapeutics' Return on Sales [ROS] was -3063.98% in FY2024 (+9832.46 pp) and -12896.43% in FY2023.
- The Q2 2026 figure stands as the lowest quarterly Return on Sales [ROS] in data going back to Q4 2023.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last three quarters, with an average year-over-year change of -43978.72 percentage points over the last four quarters.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -14908.22% (Q1 2026), -5279.20% (Q4 2025) and -38640.40% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 32.98% |
| 10 | Odyssey Therapeutics | 929.15 Mn | -64.53 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -173,008.08% |
| Mar 31, 2026 | -14,908.22% |
| Dec 31, 2025 | -5,279.20% |
| Sep 30, 2025 | -38,640.40% |
| Jun 30, 2025 | -4,371.32% |
| Mar 31, 2025 | -2,041.71% |
| Dec 31, 2024 | -2,136.98% |
| Dec 31, 2023 | -10,867.60% |
Odyssey Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ODTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ODTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ODTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();